6LPN
Crystal structure of human D-2-hydroxyglutarate dehydrogenase in apo form
Summary for 6LPN
Entry DOI | 10.2210/pdb6lpn/pdb |
Descriptor | D-2-hydroxyglutarate dehydrogenase, mitochondrial, FLAVIN-ADENINE DINUCLEOTIDE (3 entities in total) |
Functional Keywords | dehydrogenase, flavoprotein, oxidoreductase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 106236.85 |
Authors | |
Primary citation | Yang, J.,Zhu, H.,Zhang, T.,Ding, J. Structure, substrate specificity, and catalytic mechanism of human D-2-HGDH and insights into pathogenicity of disease-associated mutations. Cell Discov, 7:3-3, 2021 Cited by PubMed Abstract: D-2-hydroxyglutarate dehydrogenase (D-2-HGDH) catalyzes the oxidation of D-2-hydroxyglutarate (D-2-HG) into 2-oxoglutarate, and genetic D-2-HGDH deficiency leads to abnormal accumulation of D-2-HG which causes type I D-2-hydroxyglutaric aciduria and is associated with diffuse large B-cell lymphoma. This work reports the crystal structures of human D-2-HGDH in apo form and in complexes with D-2-HG, D-malate, D-lactate, L-2-HG, and 2-oxoglutarate, respectively. D-2-HGDH comprises a FAD-binding domain, a substrate-binding domain, and a small C-terminal domain. The active site is located at the interface of the FAD-binding domain and the substrate-binding domain. The functional roles of the key residues involved in the substrate binding and catalytic reaction and the mutations identified in D-2-HGDH-deficient diseases are analyzed by biochemical studies. The structural and biochemical data together reveal the molecular mechanism of the substrate specificity and catalytic reaction of D-2-HGDH and provide insights into the pathogenicity of the disease-associated mutations. PubMed: 33431826DOI: 10.1038/s41421-020-00227-0 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.206 Å) |
Structure validation
Download full validation report